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Abstract
Background: Chronic non-specific low back pain is a major socioeconomic public health issue worldwide and,
despite the volume of research in the area, it is still a difficult-to-treat condition. The conservative analgesic therapy usually
comprises a variety of pharmacological and non-pharmacological strategies, such as transcutaneous electrical
nerve stimulation. The neuromatrix pain model and the new findings on the process of chronicity of pain point
to a higher effectiveness of treatments that address central rather than peripheral structures. The transcranial direct
current stimulation is a noninvasive technique of neuromodulation that has made recent advances in the treatment of
chronic pain. The simultaneous combination of these two electrostimulation techniques (cerebral and peripheral) can
provide an analgesic effect superior to isolated interventions. However, all the evidence on the analgesic efficacy of
these techniques, alone or combined, is still fragmented. This is a protocol for a randomized clinical trial to investigate
whether cerebral electrical stimulation combined with peripheral electrical stimulation is more effective in relieving pain
than the isolated application of electrical stimulations in patients with chronic nonspecific low back pain.
Methods/Design: Ninety-two patients will be randomized into four groups to receive transcranial direct current
stimulation (real/sham) + transcutaneous electrical nerve stimulation (real/sham) for 12 sessions over a period of four
weeks. The primary clinical outcome (pain intensity) and the secondary ones (sensory and affective aspects of pain,
physical functioning and global perceived effect) will be recorded before treatment, after four weeks, in Month 3 and
in Month 6 after randomization. Confounding factors such as anxiety and depression, the patient’s satisfaction with
treatment and adverse effects will also be listed. Data will be collected by an examiner unaware of (blind to) the
treatment allocation.
Discussion: The results of this study may assist in clinical decision-making about the combined use of cerebral
and peripheral electrical stimulation for pain relief in patients with chronic low back pain.
Trial registration: NCT01896453
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Background
Low back pain is one of the main musculoskeletal com-
plaints in clinics and hospitals and is still one of the six
most often found health conditions in developed countries
[1]. In Brazil, this condition is the second most prevalent
chronic health condition, second only to systemic venous
hypertension [2]. Recent estimates suggest a prevalence of
11.9%, and the overall number of individuals with low
back pain considerably increases with the aging popula-
tion [3]. The breadth of this condition’s socioeconomic
impact and its effect on quality of life make it one of the
greatest public health challenges worldwide [4-6].
Many efforts have been made to find effective treat-
ments; however, back pain remains difficult to treat [7].
Conservative analgesic therapy usually comprises a variety
of strategies, such as medication, acupuncture, kine-
siotherapy, manual and behavioral therapy, multidisciplin-
ary approaches and the use of physical methods such as
transcutaneous electrical nerve stimulation (TENS) [8,9].
Despite being used for more than 20 years, TENS still pre-
sents controversial results, thus hampering its use as an
effective treatment for chronic non-specific [10-13] low
back pain. Many studies showing some evidence of TENS
for pain relief show methodological flaws; in addition, the
long-term benefits of this technique are not clear, as the
effects occur especially during application [14,15].
New concepts like neuromatrix of Melzack [16] propose
participation of brain mechanisms in pain chronicity, thus
holding in check treatments that exclusively address per-
ipheral structures. Moreover, studies focusing on neuro-
imaging showed structural and functional changes in the
cerebral cortex of people with chronic musculoskeletal
pain [17-19]. In the brain, sensorimotor control mecha-
nisms therefore seem to contribute to the emergence and
maintenance of the painful condition. Although some
studies have shown that peripheral stimulation such as
high frequency TENS can inhibit cortical excitability
[20-22] this technique could be insufficient in modulating
peripheral and central pain amplification, especially at en-
cephalic levels, where “ill plastic adaptations” occur as a
result of chronic low back pain [23-25].
Accordingly, treatments specifically addressing the cere-
bral cortex can complement the action of peripheral inter-
ventions and result in a more effective tool for the relief of
chronic pain. The transcranial direct current stimulation
(tDCS), despite not being a new modality, has presented
recent advances in the treatment of chronic pain [26-30],
establishing itself as a promising therapeutic tool. Like
TENS, tDCS is a well-tolerated noninvasive low-cost tech-
nique with minimal side effects [31,32].
According to our literature review, there are only three
studies involving the tDCS technique in chronic nonspe-
cific low back pain: (1) a protocol study without prior re-
sults [33], (2) an exploratory study with only one
application of tDCS [34] and (3) an exploratory random-
ized double-blind study [35]. Taken together, these studies
showed no significant differences in pain relief between
real and sham tDCS. Although the results may indicate
that transcranial stimulation may not be enough to change
the perception of pain, conclusions about the effectiveness
of this technique in chronic low back pain should be cau-
tious in view of the characteristics of the experiments.
Transcranial stimulation associated with peripheral stimu-
lation was investigated in only two studies. In patients
with neurogenic pain in the arm, the combination of these
techniques achieved greater reduction in pain than the
isolated application of transcranial stimulation [36]. In
a recent study, Siobhan and colleagues (2014) demon-
strated that the combination of peripheral and transcra-
nial stimulation was more effective in relieving the
symptoms of chronic low back pain and mechanisms of
cortical organization and sensitization than the inter-
ventions applied alone [37]. The promising results of
these two cross-sectional clinical studies indicate the
possibility of a synergistic action of the cortical and
peripheral stimulation, and hence a more potent anal-
gesic effect. However, there is a critical need for ran-
domized clinical trials to generalize these findings and
produce the best data available for clinical decision-
making.
The identification of effective non-invasive and non-
pharmacological treatments can trigger a substantial gain
in pain relief and physical capacity, resulting in decreased
morbidity and lower costs associated with low back pain.
By simultaneously combining the two electrical stimula-
tion techniques (cerebral and peripheral), the analgesic ef-
fect could be enhanced by the reorganization of cortical
neuron activity and by the segmental inhibition of noci-
ceptive stimulus. The aim of this experiment is to investi-
gate whether cerebral and peripheral electrical stimulation
combined are more effective in relieving pain than the iso-
lated application of electrical stimulations in patients with
chronic nonspecific low back pain.
Objective
The primary objective of this study is to investigate the
analgesic efficacy of transcranial (cerebral) direct current
stimulation combined with transcutaneous (peripheral)
electrical nerve stimulation in patients with chronic
nonspecific low back pain compared with cerebral and
peripheral electrical stimulations applied alone. The an-
algesic efficacy will be analyzed through the decrease of
pain intensity four weeks after randomization.
The secondary objectives are:
To analyze the difference between cerebral, peripheral
and combined stimulations in pain intensity in patients
with chronic nonspecific low back pain assessed in
Month 3 and in Month 6 after randomization.
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To analyze the difference between cerebral, peripheral
and combined stimulations in the sensory and affective
aspects of pain in patients with chronic nonspecific low
back pain assessed after four weeks, in Month 3 and in
Month 6 after randomization.
To analyze the difference between cerebral, peripheral
and combined stimulations in the functional capacity of
patients with chronic nonspecific low back pain assessed
after four weeks, in Month 3 and in Month 6 after
randomization.
To analyze the difference between cerebral, peripheral
and combined stimulations in the perception of the
overall effect of patients with chronic nonspecific low
back pain assessed after four weeks, in Month 3 and in
Month 6 after randomization.
To analyze the patients’ satisfaction with the treatment.
Hypothesis
Our hypothesis is that tDCS and TENS simultaneously
combined are more effective in reducing the intensity
and sensory aspect of pain, presenting less disability and
having a better effect on global perception when com-
pared to patients receiving the treatments alone.
Methods/Design
A controlled factorial (2 × 2) clinical trial will be con-
ducted to evaluate the analgesic efficacy of cerebral and
peripheral stimulation in chronic low back pain (Figure 1).
Approval and registration
This project was approved by the Ethics Committee of
the School of Medicine, University of São Paulo (USP)
(protocol 308/13). The study will be conducted at the
Clinical School of Physiotherapy, School of Medicine,
USP, and at the Rehabilitation Center of the Irmandade
da Santa Casa de Misericórdia de São Paulo, São Paulo,
Brazil.
Procedures
Patients with complaints of low back pain who seek
treatment at the physiotherapy clinic of the School of
Medicine, USP, and at the physiotherapy clinic of the
Irmandade da Santa Casa de Misericórdia de São Paulo,
will be initially evaluated by the medical staff of the in-
stitutions. After the diagnosis of chronic nonspecific
low back pain and referral to the physiotherapy ser-
vices, the patients will be thoroughly informed about
the present study. The physiotherapist responsible for
Figure 1 Flow chart illustrating the process of the study. tDCS and TENS indicate transcranial direct current stimulation and transcutaneous
electrical nerve stimulation, respectively.
Hazime et al. BMC Musculoskeletal Disorders  (2015) 16:7 Page 3 of 8
the evaluations will clarify the objectives of the study,
possible treatments, eligibility criteria and potential
risks resulting from the application of cerebral and per-
ipheral stimulations. Patients who agree to the condi-
tions and sign the consent form may participate.
Participants who meet the eligibility criteria will be in-
cluded in the study.
Participants and eligibility
This study will involve 92 participants (both genders)
who seek treatment at one of our rehabilitation centers
through medical referral complaining of nonspecific low
back pain for more than three months.
Participants who meet the following criteria will be eli-
gible: (1) age between 18 and 65 years, (2) medical diag-
nosis of nonspecific low back pain present for at least
three months, (3) spontaneous search for treatment and
(4) signature of informed consent.
Participants will be excluded from the survey under
the following conditions: (1) low back pain assessed <4
by Numeric Rating Scale (NRS) during one-week daily
monitoring (patient registration); (2) previous spine sur-
gery less than six months ago; (3) previous treatment
with TENS less than six months ago; (4) previous tDCS
treatment; (5) disk herniation with nerve compression
with neurological compromise; (6) neurological, psychi-
atric and rheumatologic diseases; (7) use of pacemakers
or other implanted devices; (8) pregnancy; (9) drug use
and (10) abuse of medicines and alcoholic beverages.
The regular use of prescribed medications will not be
an exclusion criterion, but the dose and type of medica-
tion will be recorded and documented. Patients with
moderate psychiatric comorbidities such as anxiety and
depression that are under medical supervision will not
be excluded.
Randomization and allocation concealment
Before starting treatment, a randomized generating pro-
gram will place patients in one of the four groups: (1) real
transcranial direct current stimulation (tDCS-r) + real
transcutaneous electrical nerve stimulation (TENS-r), (2)
real transcranial direct current stimulation (tDCS-r) +
sham transcutaneous electrical nerve stimulation (TENS-
s), (3) sham transcranial direct current stimulation (tDCS-
s) + real transcutaneous electrical nerve stimulation
(TENS-r) and (4) sham transcranial direct current stimu-
lation (tDCS-s) + sham transcutaneous electrical nerve
stimulation (TENS-s). The randomization and allocation
concealment will be carried out by a collaborator not par-
ticipating in the research, who should organize the pa-
tients’ records and their previously allocated treatments in
individual opaque envelopes. The schedule of treatment
will be revealed to the physiotherapist responsible for the
treatments at the moment of electrical stimulation
application. The “blinding” of evaluator and patients will
be kept until the end of the research and data processing.
Initial evaluation
After the fulfillment of eligibility and subsequent adher-
ence and signature of the consent term, information on
participants will be collected through a structured
interview. Data will include personal data, clinical
history and radiological findings (if any) and anthropo-
metric characteristics. Subsequently, a clinical psycho-
functional evaluation will be conducted according to
the recommendations of the Initiative on Methods,
Measurement, and Pain Assessment in Clinical Trials
(IMMPACT) for clinical trials of effectiveness of treat-
ment for chronic pain [38]. The main outcomes to be
included in the clinical trials include six aspects: (1)
pain, (2) physical functioning, (3) emotional function-
ing, (4) classification of improvement and patient’s sat-
isfaction, (5) symptoms and adverse events and (6)
patient’s approval.
Primary variable
Pain intensity
Pain intensity will be assessed on a numerical scale of 11
points (0–10), 0 accounting for no pain and 10 for the
worst pain possible. The patient will be asked to describe
the pain of the past seven days [39]. Pain intensity will
also be assessed before and immediately after the appli-
cation of protocols over the 12 sessions.
Secondary variables
Sensory and affective aspects of pain
The short version of the McGill Questionnaire (SF-
MPQ) contains 15 descriptors of pain sensation (11
sensory and four affective), each descriptor rated on a
4-point scale where 0 = none, 15 = mild, 25 = moderate,
and 35 = severe [40]. Three measurements of pain ex-
perience based on sensory and affective descriptors can
be obtained: (1) PRI-T is the sum of all 15 descriptors
with the total score ranging from 0 to 45, (2) PRI-S
(sensory) is the sum of descriptors 1 through 11 with
the total score ranging from 0 to 33 and (3) PRI-A
(affective) consists of the sum of descriptors 12 to 15
with the total score ranging from 0 to 12. The SF-MPQ
also includes the visual analog scale (VAS) and the
present pain intensity (PPI) of the long version of Mc-
Gill questionnaire.
Physical functioning
The Roland Morris disability questionnaire assesses the
overall functional capacity of the patient through the phys-
ical limitations resulting from low back pain. The question-
naire consists of 24 questions related to the normal
activities of daily life, each affirmative answer corresponding
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to one point. The final score is determined by the sum of
the scores. Values close to zero mean the best results, i.e.
lower limitation, and values close to 24, the worst results,
i.e. greater limitation. The highest number of responses is
related to greater disability due to low back pain [39,41,42].
Perception of global effect
The effect felt as a result of treatment will be assessed
by the scale of global perceived effect that assesses the
perceived level of the patient’s recovery from the treat-
ment, comparing the initial symptoms with those of the
last days. The resource is a numerical 11-point scale ran-
ging from −5 to +5, with −5 = extremely ill, zero = no
change, and +5 = completely recovered, with the highest
score representing the fullest recovery [39].
Other outcomes
Emotional functioning - confusion factors
Depression and anxiety may be important confounding
factors that influence the improvement of the patient’s
pain. Thus, symptoms of depression and general anxiety
will be assessed at the beginning and the end of treat-
ment by the Brazilian version of the Beck Depression In-
ventory (BDI) [43] and Visual Analog Scale (VAS),
respectively. The BDI is a tool of self-assessment of de-
pression using a questionnaire with 21 items whose in-
tensity varies from 0 to 3 (higher scores indicating more
depressive symptoms). The VAS for general anxiety is
assessed by a horizontal 100-mm-long line. The extreme
left end points to no anxiety, and the extreme right end
to the worst anxiety possible [44].
Symptoms and adverse events
The record of symptoms and adverse events resulting
from the use of tDCS and TENS is passively collected by
the patient’s spontaneous reports. Active collection uses
a questionnaire with records of the duration and inten-
sity of adverse symptoms reported by the patient. Then
the patients will be asked to rank the certainty of their
claims according to a Likert scale (1 = no certainty and
5 = total certainty) [31].
Patients’ approval
The approval of patients receiving treatment will be
evaluated by the Medrisk questionnaire, which measures
the satisfaction of patients undergoing physical therapy
care. This questionnaire consists of 20 items, 10 of them
related to the therapist-patient interaction, eight not re-
lated to it and two items considered overall items. The
patient chooses his or her level of satisfaction with each
item by selecting a Likert-like scale ranging from 1
(“strongly disagree”) to 5 (“strongly agree”) or by choos-
ing option “not applicable,” where high scores represent
high satisfaction [45].
Evaluation of the blind condition
The evaluation of the blind condition of patients and the
evaluator-therapist will be conducted at the end of four
weeks of treatment. Both will be asked to guess which
intervention was used for tDCS and TENS, whether real
or sham. Then patient and evaluator will be required to
rank the certainty of their claims according to a Likert-
like scale (1 = no certainty, 5 = total certainty). To ensure
that the evaluator is not induced to correctly guess the
participants’ allocation, the latter will be instructed not
to reveal which sensation was felt during the sessions.
Treatments
The treatment will be carried out for four weeks, with
three sessions per week, totaling 12 sessions of electrical
stimulation. The sessions will take place individually in
schedules of alternate days from Monday to Saturday.
The program of schedules will allow a 20-minute inter-
val between sessions so as to avoid possible contact be-
tween patients.
Measurements of the participants’ expectations
After the enrollment and initial assessment (pre-treat-
ment) and before randomization, the participants will be
informed about the possible sensations arising from cere-
bral and peripheral stimulations. They will be informed
that the unit of electrical stimulation may cause a slight
tingling, itching or burning sensation the entire time or
only at the beginning of application. The difference in sen-
sations occurs according to the sensitivity of each individ-
ual. Participants will also be informed about the possibility
of no perceptible sensation during the procedure. Regard-
less of the stimulus felt, all participants will be instructed
not to reveal the sensation experienced.
Transcranial Direct Current Stimulation (tDCS)
The transcranial stimulation is applied by a DC generator
powered by a 9-volt battery (Activadose II, USA). The
current will be applied using two electrodes (35 cm2; 5 ×
7 cm) (Ibramed, Brazil) covered by a sponge damped with
physiologic saline (salt solution 1%) and fixed to the head
with elastic bands.
The assembly of the electrodes will be made accord-
ing to the International 10–20 System of EEG [46] to
better focus the primary motor cortex. The positively
charged electrode (anode) will be placed at C3 or C4
(counterlateral to the side of pain complaint), and the
negatively charged electrode (cathode) in the supra-
orbital ipsilateral region [29]. For patients experiencing
pain in the central region of the lumbar spine, the
anode will be placed on the side counterlateral to the
dominant upper limb of the patient, as described in
previous studies [47,48].
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The groups that receive the real tDCS (tDCS-r) will be
treated with electrical current intensity of 2 mA, density
of 0.057 mA/cm2 and application time of 20 minutes
[29]. The groups with sham tDCS (tDCS-s) will receive
cerebral stimulation within the same parameters, but the
application time will be only 30 seconds [35]. This fea-
ture of sham stimulation is usually used [47,48] because
the tingling sensation on the skin below the electrode
usually disappears after 30s. Thus, the placebo effect is
more effectively monitored.
Transcutaneous Electrical Nerve Stimulation (TENS)
The peripheral stimulation will be applied through a
rectangular asymmetric two-phase electrical current ap-
paratus (Neurodyn III Ibramed, Brazil). Both units of
stimulation (real or sham) will be applied, using four
self-adhesive electrodes (VALUTRODE 5 × 9 cm). The
electrodes will be placed in a paralleled and bilateral
position of the lumbar segment on the painful area.
The groups that will receive the real TENS (TENS-r)
will be treated with current intensity (amplitude) accord-
ing to their sensory threshold, characterized as an in-
tense, yet comfortable, pulse frequency of 100 Hz, pulse
duration of 200 μs and application time of 40 minutes
[15]. During application, the patients will be asked about
their perception of TENS intensity every five minutes
and, when they get used to the sensation, the intensity
will be increased again until the return of the sensory
threshold.
Although some studies report no differences between
high (100 Hz) and low (4 Hz) frequency for the treatment
of chronic low back pain [13], prolonged use of opioid an-
algesics (activation of μ receptors) can induce tolerance to
the drug and interfere with the effect of TENS, especially
when low frequency is used [49]. Groups with sham nerve
stimulation (TENS-s) will receive the same stimulation
parameters, but the application time, like sham tDCS, will
be only 30 seconds. The sham and the real TENS equip-
ment will have the same appearance, but, after the initial
30 seconds, the current amplitude will gradually decrease
to 15 seconds until it reaches zero, thereby stopping the
issuance of the electric current. The equipment will re-
main inactive for the rest of the application, maintaining a
light on during the whole process. The same occurs with
the real stimulation machine.
Sample size
The sample size was a priori estimated by the analysis of
power [50] to detect a clinically important minimal dif-
ference (10% reduction from the baseline) in the out-
come of pain intensity measured by the Numerical
Rating Scale for Pain [51]. The effect size and the prob-
ability of error type 1 (α) and type 2 (β) were 0.33, 0.05
and 0.20, respectively. According to the data of sample
calculation, there must be a total of 75 participants.
However, considering 20% of sample loss, a sample size
of 92 participants (23 per group) was calculated.
Statistical analysis
All statistical procedures will be performed according to
the principles of intention to treat. Linear mixed models
will be used to identify intra- and inter-group differences
at the end of treatment and in Month 3 and Month 6 of
follow-up. All data will be analyzed using software SPSS
v.20 for Windows. The level of significance is 0.05.
Discussion
According to our review, this is the first randomized
double-blind clinical trial to investigate the analgesic ef-
ficacy of transcranial direct current stimulation (tDCS)
combined with transcutaneous electrical nerve stimula-
tion (TENS) in patients with chronic nonspecific low
back pain. The factorial design used in this study will
allow three interventions to be evaluated simultaneously:
cerebral stimulation, peripheral stimulation and com-
bined stimulation. Furthermore, the use of sham tDCS
and sham TENS represents a more robust experimental
design to control the placebo effects. The results of this
study will provide important information for clinical
practice and conservative management of chronic low
back pain. The possibility of synergistic and additive ef-
fect of these noninvasive, nonpharmacological, well-
tolerated techniques presenting minimal adverse effects
can turn them into a promising therapeutic tool for
health professionals, improving the health status of the
population and reducing the socioeconomic conse-
quences of chronic low back pain.
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